Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New Drug Application
Biotech
2 eye disease biotechs merge, set sights on FDA approval
London-based Tenpoint and Seattle-based Visus have merged, tapping Henric Bjarke to helm the new entity.
Gabrielle Masson
Dec 12, 2024 11:05am
Elevar offers $500M biobucks for Relay's rare cancer asset
Dec 3, 2024 3:04pm
Aldeyra preps for FDA refiling as dry eye drug hits ph. 3 goal
Aug 8, 2024 10:48am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am
Milestone resubmits NDA, Aldeyra readies 2nd chance filing
Mar 28, 2024 10:40am
Tonix signs CRO deal, preps FDA app for fibromyalgia drug
Feb 14, 2024 12:52pm
